Relapses in idiopathic inflammatory myopathies [3] (multiple letters)

Muscle and Nerve

Volumn 22, Issue 8, 1999, Pages 1159-1160

  Miró, Òscar ^a   Laguno, Montserrat ^a   Grau, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; METHOTREXATE; PREDNISOLONE;

ADULT; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DYSPHAGIA; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL; RELAPSE;

EID: 0032769345     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4598(199908)22:8<1159::aid-mus29>3.3.co;2-y     Document Type: Letter

References (5)

1. Henriksson KG, Sandstedt P. Polymyositis: treatment and prognosis. A study of 107 patients. Acta Neurol Scand 1982; 65:280-300.
2. Lee W, Zimmermann B, Lally EV. Relapse of polymyositis after prolonged remission. J Rheumatol 1997;24:1641-1644.
3. Miró O, Laguno M, Alonso JR, Casademont J, Herrero C, Selva A, Urbano-Márquez A, Grau JM. Evolución de las miopatías inflamatorias idiopáticas: complicaciones, supervivencia y factores pronóstico. Med Clin (Bare). 1999;112:521-526.
4. Phillips BA, Zilko P, Garlepp MJ, Mastaglia FL. Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle Nerve 1998;21:1668-1672.
5. Tyndall A. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus. J Rheumatol 1997;24:94-97.